The tuberculosis treatment success rate for previously treated cases in the UK showed a forecasted stabilization based on the data from 2024 to 2028, hovering around 74% in 2024 and reaching 75% by 2025, maintaining this level through 2028. In 2023, the rate was similar, suggesting minimal year-on-year change at the start of the period. The Compound Annual Growth Rate (CAGR) is approximately 0.33% over the five-year span, indicating a slight expected improvement in treatment success rates.
Future trends to watch for include the impact of new treatment protocols, emerging drug resistance, and public health strategies, which could influence treatment success rates. Continued investment in healthcare infrastructure and research may help improve outcomes moving forward.
